Page last updated: 2024-11-06

trichloroacetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID61144
CHEMBL ID331157
SCHEMBL ID116271
MeSH IDM0054320

Synonyms (47)

Synonym
EN300-19420
.alpha.,.alpha.,.alpha.-trichloroacetamide
acetamide, 2,2,2-trichloro-
2,2,2-trichloroacetamide
brn 1754028
amid kyseliny trichloroctove [czech]
einecs 209-849-3
ai3-15484
nsc 16599
acetamide, alpha-trichloro-
wln: zvxggg
594-65-0
2,2-trichloroacetamide
trichloroacetamide
acetamide, .alpha.-trichloro-
nsc16599
nsc-16599
.alpha.,.alpha.-trichloroacetamide
trichloroacetimidate on wang resin, 100-200 mesh, extent of labeling: 0.75-1.25 mmol/g trichloroacetimidate loading, 1 % cross-linked
trichloroacetimidate on wang resin, 200-400 mesh, extent of labeling: 0.75-1.25 mmol/g trichloroacetimidate loading, 1 % cross-linked
trichloroacetamide, 99%
CHEMBL331157 ,
2,2,2-trichloro-acetamide
T0368
AKOS004906855
NCGC00248683-01
NCGC00258090-01
dtxsid5021671 ,
dtxcid801671
cas-594-65-0
tox21_200536
unii-i8bl3305ro
i8bl3305ro ,
4-02-00-00520 (beilstein handbook reference)
amid kyseliny trichloroctove
FT-0632474
SCHEMBL116271
Q-201861
trichloro-acetamide
2,2,2-chloroacetamide
F8889-7125
mfcd00008009
AS-12016
bdbm50226187
Q27280571
SY049543
Z104473774

Research Excerpts

Overview

Trichloroacetamide (TCAcAm) is an emerging nitrogenous DBP. TCAcAm could induce some changes associated with host-gut microbiota co-metabolism.

ExcerptReferenceRelevance
"Trichloroacetamide (TCAcAm) is an emerging nitrogenous DBP, and our previous study found that TCAcAm could induce some changes associated with host-gut microbiota co-metabolism."( Metagenomic and metabolomic analysis of the toxic effects of trichloroacetamide-induced gut microbiome and urine metabolome perturbations in mice.
Deng, Y; Ren, H; Zhang, Y; Zhao, F; Zhao, Y, 2015
)
1.38

Toxicity

ExcerptReferenceRelevance
" In this study, we used an integrated approach combining metagenomics, based on high-throughput sequencing, and metabolomics, based on nuclear magnetic resonance (NMR), to evaluate the toxic effects of TCAcAm exposure on the gut microbiome and urine metabolome."( Metagenomic and metabolomic analysis of the toxic effects of trichloroacetamide-induced gut microbiome and urine metabolome perturbations in mice.
Deng, Y; Ren, H; Zhang, Y; Zhao, F; Zhao, Y, 2015
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency36.72260.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency68.86870.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency77.27200.000221.22318,912.5098AID743042
estrogen nuclear receptor alphaHomo sapiens (human)Potency68.86870.000229.305416,493.5996AID743079
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency46.91970.000627.21521,122.0200AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alcohol dehydrogenase E chainEquus caballus (horse)Ki8,511.37990.14122.89278.7000AID33855
Alcohol dehydrogenase S chainEquus caballus (horse)Ki8,511.37990.14122.89278.7000AID33855
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID33855Inhibitory activity against horse liver alcohol dehydrogenase (ADH)1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
A quantitative structure-activity relationship and molecular graphics analysis of hydrophobic effects in the interactions of inhibitors with alcohol dehydrogenase.
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID23467Partition coefficient (logP)1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
A quantitative structure-activity relationship and molecular graphics analysis of hydrophobic effects in the interactions of inhibitors with alcohol dehydrogenase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (103)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.94)18.7374
1990's4 (3.88)18.2507
2000's39 (37.86)29.6817
2010's52 (50.49)24.3611
2020's6 (5.83)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.18 (24.57)
Research Supply Index4.66 (2.92)
Research Growth Index5.40 (4.65)
Search Engine Demand Index36.32 (26.88)
Search Engine Supply Index2.35 (0.95)

This Compound (28.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.90%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other103 (98.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]